Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Immunohistochemistry Market: By Product, Reagents, Equipment, Kits ), By Application, Research Applications, Forensic applications), By End-User and Region Forecast 2019-2030
Immunohistochemistry (IHC) Market size was valued at US$ 2.8 billion in 2023 and is poised to grow at a significant CAGR of 8.5% from 2024-2030. Since personalized medicine has shown to be quite successful in treating non-small-cell lung cancer patients, its use is anticipated to rise. By providing the most thorough and precise histological subtyping of tumors feasible, immunohistochemistry techniques enable this method of treatment decision-making (supported by predictive immunohistochemistry and the assessment of relevant biomarkers).
The market is growing due to the rise in product approvals and the introduction of technologically sophisticated IHC equipment for illness diagnostics. To improve their market position, businesses keep releasing innovative items that generate income. The leading players are launching new products, merging with other companies, expanding regionally, and engaging in other strategic efforts in the field of IHC to address the growing demand for IHC assays in cancer diagnostics.
Additionally, the improved accessibility of immunohistochemical assays that identify mutant proteins (such as BRAF V600E and IDH1 R132H) offers a useful substitute or supplementary method to molecular testing. These methods are valuable novel tools in contemporary cancer care since they are highly reproducible, involve a manageable level of technical and interpretative complexity, and are accessible for comparatively little money. Furthermore, multiplex and mutation-specific immunohistochemistry tests are significant advances that have boosted value in targeted therapy and personalized medicine. The demand for IHC in disease diagnosis has increased significantly due to improvements in IHC methods.
Study Period
2024-2030Base Year
2023CAGR
8.5%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The aging population will benefit the growth of the IHC market in both established and developing regions. The prevalence of age-related disorders is anticipated to rise dramatically with the worldwide geriatric population's rapid growth. In 2019, there were 54 million senior persons living in the US, according to the OECD. Other wealthy nations have sizable and expanding geriatric populations as well. The chance of contracting diseases rises proportionately with age. Therefore, it is anticipated that the prevalence of various diseases will increase globally as the senior population grows. This is considered a significant element are propelling the IHC market for diagnostic applications. On the other hand, immunohistochemistry is expected to have a slow development rate due to the low specificity of IHC techniques and their expensive setup costs.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 2.8 billion |
Market CAGR |
8.5% |
By Product Type |
|
By Application |
|
By End User |
|
By Region |
|
Download Free Sample Report
The immunohistochemistry market size was valued at US$ 2.8 billion in 2023
The immunohistochemistry market key players are: Thermo Fisher Scientific Inc. Hoffmann-La Roche Ltd. Merck KGaA Danaher Corporation Perkinelmer, Inc. Bio-Rad Laboratories, Inc. Cell Signaling Technology, Inc. Bio SB Agilent Technologies, Inc. Abcam plc.
US is the biggest market for Immunohistochemistry Market followed by Europe region.
1.Executive Summary |
2.Global Immunohistochemistry Market Introduction |
2.1.Global Immunohistochemistry Market - Taxonomy |
2.2.Global Immunohistochemistry Market - Definitions |
2.2.1. By Product Type |
2.2.2. By Application |
2.2.3. By End-user |
2.2.4.Region |
3.Global Immunohistochemistry Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Immunohistochemistry Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Immunohistochemistry Market By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Antibodies |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Equipment |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Reagents |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Kits |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6.Global Immunohistochemistry Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Diagnostics |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Drug Testing |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7.Global Immunohistochemistry Market By End-user, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospitals and Diagnostic Laboratories |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Research Institutes |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Immunohistochemistry Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Immunohistochemistry Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Antibodies |
9.1.2.Equipment |
9.1.3.Reagents |
9.1.4.Kits |
9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Diagnostics |
9.2.2.Drug Testing |
9.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals and Diagnostic Laboratories |
9.3.2.Research Institutes |
9.3.3.Others |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Immunohistochemistry Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Antibodies |
10.1.2.Equipment |
10.1.3.Reagents |
10.1.4.Kits |
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Diagnostics |
10.2.2.Drug Testing |
10.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals and Diagnostic Laboratories |
10.3.2.Research Institutes |
10.3.3.Others |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Immunohistochemistry Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Antibodies |
11.1.2.Equipment |
11.1.3.Reagents |
11.1.4.Kits |
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Diagnostics |
11.2.2.Drug Testing |
11.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals and Diagnostic Laboratories |
11.3.2.Research Institutes |
11.3.3.Others |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Immunohistochemistry Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Antibodies |
12.1.2.Equipment |
12.1.3.Reagents |
12.1.4.Kits |
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Diagnostics |
12.2.2.Drug Testing |
12.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals and Diagnostic Laboratories |
12.3.2.Research Institutes |
12.3.3.Others |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Immunohistochemistry Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Antibodies |
13.1.2.Equipment |
13.1.3.Reagents |
13.1.4.Kits |
13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Diagnostics |
13.2.2.Drug Testing |
13.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals and Diagnostic Laboratories |
13.3.2.Research Institutes |
13.3.3.Others |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Thermo Fisher Scientific Inc. |
14.2.2.Hoffmann-La Roche Ltd. |
14.2.3.Merck KGaA |
14.2.4.Danaher Corporation |
14.2.5.Perkinelmer, Inc. |
14.2.6.Bio-Rad Laboratories, Inc. |
14.2.7.Cell Signaling Technology, Inc. |
14.2.8.Bio SB |
14.2.9.Agilent Technologies, Inc. |
14.2.10.Abcam plc. |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players